Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia

Fig. 5

Testing the TCGAPT-derived RSF prognosis model with GMI signature on the TCGAPO. a Kaplan-Meier survival curves from 5-fold cross-validation results of the TCGAPT-derived RSF prognosis model. b Testing the TCGAPT-derived RSF prognosis model on independent test dataset TCGAPO. Kaplan-Meier survival curves derived for the risk stratification of TCGAPO dataset

Back to article page